The medtech company says it is the only manufacturer of FDA-approved pulse oximeters to have reached an agreement in a lawsuit against many over the devices' notoriously higher rates of error for people with darker skin.
Subscribe to:
Post Comments (Atom)
< + > The Myth of the Single Healthcare Decision-Maker and Other Reuters Digital Health 2026 Insights
Sometimes you only need a morning to get a read on a room. I dropped into the Reuters Digital Health 2026 event in Chicago for just a half...
No comments:
Post a Comment